GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (XCNQ:BBM) » Definitions » Research & Development

Blueberries Medical (XCNQ:BBM) Research & Development : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Blueberries Medical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Blueberries Medical's Research & Development for the three months ended in Sep. 2024 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

Blueberries Medical Research & Development Historical Data

The historical data trend for Blueberries Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical Research & Development Chart

Blueberries Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Blueberries Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Blueberries Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blueberries Medical  (XCNQ:BBM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Blueberries Medical Research & Development Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Blueberries Medical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (XCNQ:BBM) » Definitions » Research & Development
Comparable Companies
TSXV:ENTG XCNQ:LOBE XCNQ:AION XCNQ:LOWL XCNQ:HERB TSXV:DHB XCNQ:VIBE XCNQ:BCBC XCNQ:THC TSXV:HMPG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
BBRRF:USA 1OA:Germany
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Website
https://www.blueberriesmed.com
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Executives
Guillermo Pablo Rodriguez Senior Officer
Facundo Garreton Director
Ian D Atacan Senior Officer
Camilo Villalba Gómez Senior Officer

Blueberries Medical Headlines

No Headlines